Transcranial Direct Current Stimulation (tDCS) is a type of neuromodulation that was developed decades ago but has generated more interest in recent years. We discuss the evidence for tDCS for depression, and cover the outcomes from some recent studies. Introduction What is Transcranial Direct Current Stimulation (tDCS) for depression? tDCS is the application of a …
We are often asked about rTMS for depression, particularly whether it is available on the NHS for patients in Scotland. Below, we explore the evidence to support the use of rTMS for depression and look at how patients might access rTMS in Scotland. Introduction This is not intended to be a comprehensive review of rTMS. …
This post is a summary of a poster that was presented at the EABCT conference in 2021. We talk about behavioural modification approaches for ritualised behaviour in OCD and other disorders. The full reference is as follows: Buick, R., Cockburn, C. & Christmas, D. (2021) Applying a transdiagnostic approach to treating ritualised behaviour in specialised …
We are often asked about whether we provide or recommend esketamine as a treatment for depression. Esketamine is a particular form of ketamine, which has been used to treat depression for many years, although the evidence for long-term benefit is lacking. This is not a complete summary of the evidence for ketamine/ esketamine, but it …
We discuss the issue of higher-than-needed doses of antipsychotic medication for augmentation in OCD. This can cause side effects. We briefly review the evidence to support the use of Risperidone in treating OCD and look at typical doses. We go on to make some recommendations for optimum doses of Risperidone. Background In the last year, …
In this blog we look at a recent study of caffeine for treating OCD (Naftalovich, 2020). We provide a bit of background on why caffeine might be used and then we describe the study design, the main findings, before discussing the clinical implications. Introduction How does caffeine affect the body? Essentially, caffeine is a central …
There has been a lot of interest in psilocybin as a treatment for several mental disorders, but the evidence is only emerging. In this blog we cover a recent study looking at psilocybin as a treatment for depression (Davis et al, 2020) and discuss what the implications for patient treatment might be. What is psilocybin? Psilocybin …
Introduction N-acetylcysteine is thought to regulate glutamate neurotransmission in the brain, and also acts as a potential anti-oxidant. It increases the amount of extracellular glutamate by enhancing the activity of the cystine/ glutamate transporter. There are a number of other drugs that are sometimes used to treat OCD that act on glutamate. These include: Memantine; Riluzole, …